USPTO Patent Application: Sialic Acid Compositions for Coronavirus Infections
Summary
The USPTO has published a patent application (US20260083762A1) detailing compositions comprising sialic acid for inhibiting or treating coronavirus infections, specifically those caused by SARS-CoV-2. The application was filed on August 18, 2025, by inventor Jan Remmereit.
What changed
This document is a USPTO patent application (US20260083762A1) related to the use of sialic acid compositions to inhibit or treat coronavirus infections, particularly SARS-CoV-2. The application was filed on August 18, 2025, with inventor Jan Remmereit listed.
As this is a patent application, it does not impose immediate regulatory obligations. However, it signifies potential future developments in pharmaceutical treatments for coronaviruses. Companies in the pharmaceutical and biotechnology sectors should be aware of this filing as it may impact their research and development strategies or intellectual property landscape.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SIALIC ACID COMPOSITIONS FOR THE USE OF INHIBITING AND TREATING CORONAVIRUS INFECTION
Application US20260083762A1 Kind: A1 Mar 26, 2026
Inventors
Jan Remmereit
Abstract
The present invention relates to the use of compositions comprising sialic acid to inhibit or treat coronavirus infections, and in particular those caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
CPC Classifications
A61K 31/7012 A61P 31/14
Filing Date
2025-08-18
Application No.
19302949
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.